시장보고서
상품코드
2134016

생식 유전학 시장 : 제품 유형별, 용도별, 시술 유형별, 기술별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Reproductive Genetics Market, By Product Type, By Application, By Procedure Type, By Technology, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 299 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 4,464,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,560 금액 안내 화살표 ₩ 6,263,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 7,760,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생식 유전학 시장 규모는 2025년에 89억 510만 달러로 평가되었고, 2026-2033년 CAGR 20.9%로 성장할 전망입니다.

생식 유전학이란 유전성 질환, 염색체 수 이상 및 배아와 관련된 유전적 위험을 평가하기 위해 임신 전 또는 임신 직후에 유전자 검사를 수행하는 분야입니다. 여기에는 각종 검사, 검사 키트, 시약, 소모품 및 관련 분자 기법 등 실험실에서 개발된 검사 기법의 사용이 포함됩니다. 보조생식술 과정에서는 다음과 같은 형태의 유전자 검사가 있습니다. 즉, 수적 이상에 대한 착상 전 유전자 검사(PGT-A), 단일 유전자 질환에 대한 착상 전 유전자 검사(PGT-M), 그리고 염색체 재조합에 대한 착상 전 유전자 검사(PGT-SR)입니다. ACOG는 이러한 용도를 구분하면서도, 배아 검사는 여전히 제한된 생검 재료에 의존하고 있으며, 모자이크 현상이나 위양성·위음성 결과의 영향을 받을 가능성이 있음을 강조하고 있습니다. 따라서 이러한 기술 시장은 체외수정(IVF) 검사실, 생식 기술, 의료 진단, 배아학, 유전 상담, 그리고 유전자 기술 이용에 관한 규제 등 여러 분야의 교차점에 위치해 있으며, 재판매용 제품의 선택은 프로세스의 효율성에 의해 점점 더 결정되고 있습니다.

생식 유전학 시장 -- 시장 역학

체외수정(IVF) 워크플로우에서 유전학적 정보를 기반으로 한 배아 선별 확대

수요의 원동력은 유전자 검사 자체의 보급이 아니라, 배아 선별 과정에 유전 정보가 활용되는 범위가 확대되고 있다는 점입니다. 미국의 경우, 2025년에 발표된 CDC 통계에 따라 ART(보조생식기술)에 대한 전국적인 등록 및 통계가 확보되어, 이를 통해 생식의료시설 내 실험실 업무 데이터의 신뢰성이 강화되고 있습니다. 이와 동시에, SART는 배아 은행과 단일 배아 이식이 현대의 체외수정에서 매우 중요하다는 점을 인식하고 있으며, PGT(착상 전 유전 진단) 또한 배아학자가 이식용 배아를 선택할 수 있게 해줍니다. 이 모든 요소가 검사실에 요구되는 요건에 영향을 미치고 있으며, 검사실은 최소한의 생검 재료로 검사를 수행하고, 동결보존, 염기서열 분석, 결과 해석 및 보고 과정을 적절하게 관리할 수 있어야 합니다. 따라서 각 공급업체들은 현재 검사 능력 자체보다는 분석 통합 방식의 다양성 측면에서 경쟁을 펼치고 있습니다.

생식 유전학 시장 - 시장 세분화 분석 :

전 세계 생식 유전학 시장은 제품 유형, 용도, 시술 유형, 기술 및 지역을 기준으로 세분화되어 있습니다.

제품 유형별로는 검사실이 다양한 생식 의료 상황에 맞추어 맞춤형 분석법, 판정 절차, 워크플로우가 필요한 경우, 검사실 자체 개발 검사(LDT)가 적합합니다. 반면, 키트는 체외수정(IVF)(IVF) 및 유전학 검사실에서 일관성을 확보하는 데 도움이 되는 표준화된 검사 구성을 제공합니다. 시약 및 소모품은 배아 생검 과정의 기초가 되는 요소로 간주될 수 있습니다. 이는 분자 수준의 과정이 신뢰할 수 있는 증폭, 라이브러리 준비, 시퀀싱 수행 및 시료의 고품질 유지에 의존하기 때문입니다. LDT 범주의 규제적 중요성은 2025년에 가장 두드러지게 나타났습니다. 같은 해 3월, 연방 지방 법원이 2024년 LDT 규정을 무효로 선언했고, FDA도 이에 따라 9월에 해당 규정을 철회한 사실로 인해 그 중요성이 부각되었기 때문입니다. 따라서 규제상의 위치는 다양한 제품 유형에 영향을 미치는 중요한 요소가 됩니다.

용도별로 보면, 각 검사를 구별하는 것은 검사 방법이 아니라 특정 유전적 문제입니다. 수수성 검사는 염색체 수의 이상을 대상으로 하는 반면, 단일 유전자 질환 검사는 가족 내에서 알려진 유해 유전자를 찾아내는 데 의존합니다. 또한, 염색체 구조 이상 검사의 경우, 전좌나 역위를 특정하는 것이 목적입니다. 2025년 중국에서 실시된 다기관 공동 무작위 임상시험은 PGT-A가 여전히 논쟁의 대상이 되고 있음을 보여주는 한 예입니다. 이 시험에서는 중증 남성 요인 불임으로 고통받는 450쌍의 부부를 대상으로, PGT-A를 병용한 ICSI와 병용하지 않은 ICSI를 비교했습니다. 이 임상시험이 중요한 이유는 적용 방법의 선택이 단순히 실험 장비의 유무에 달려 있는 것이 아니라, 사용 목적의 의학적 적응증에 근거하여 이루어진다는 점을 보여주기 때문입니다. 즉, 시장에서는 자사 플랫폼에 여러 검사 옵션을 제공하면서도 적절한 결과 해석과 상담을 수행할 수 있는 기업이 높이 평가된다는 것을 의미합니다.

생식유전학 시장 - 지역별 분석

북미가 중요한 위치를 차지하는 주된 이유는 그 보조생식기술(ART) 시스템의 규모와 전문성, 그리고 전문적인 분자 검사 제공업체의 집중에 있습니다. 미국에서는 CDC의 감시 자료에 따르면 457개 클리닉에서 43만 5,426건의 ART 주기가 시행된 것으로 기록되어 있으며, 이는 생식유전학적 검사가 통합된 임상 생태계의 규모가 얼마나 큰지를 여실히 보여줍니다. 또한, 이 지역은 LDT(실험실 개발 검사)와 관련하여 매우 유연한 규제 체계를 갖추고 있습니다. FDA가 2025년에 2024년 규제를 철회함에 따라, 실험실에서 개발된 생식 검사를 둘러싼 상황이 극적으로 변화했기 때문입니다. 따라서 이 시장은 대규모 체외수정(IVF) 체인과, 실험실에 대해 분석적 타당성 확인, 문서화, 품질 관리 시스템 및 임상 전문 지식을 준수하면서 검사를 지속적으로 변경할 것을 요구하는 규제로 구성되어 있습니다.

무역 분야에서 유럽의 역할은 생식 의학 기준, 임상 거버넌스, 그리고 국경을 초월한 데이터 인프라에 관한 강력한 협력을 통해 두드러집니다. ESHRE가 시작한 EuMAR 프로그램은 2025년에 첫 3년을 마무리했으며, 에스토니아, 독일, 포르투갈,슬로베니아 등 4개국에서 실시된 시범 사업으로 구성되어 있으며, 모든 주기에서 생식 상황을 모니터링할 수 있도록 하는 것을 목적으로 했습니다. 이러한 인프라는 생식 유전학의 관점에서도 중요합니다. 표준화된 생식 데이터를 통해 서로 다른 지역의 검사 절차와 결과를 통일적으로 평가할 수 있게 되기 때문입니다. 또한, 이 지역에서는 PGT 과정, 배아 생검, 단일 유전자 질환 및 염색체 이상에 관한 권고 사항도 마련되어 있습니다. 이처럼 유럽은 거버넌스와 증거 기반의 관점에서 시장에 기여해 왔습니다.

목차

제1장 생식 유전학 시장 개요

제2장 주요 요약

제3장 생식 유전학 주요 시장 동향

제4장 생식 유전학 산업 분석

제5장 생식 유전학 시장 : 높아지는 지정학적 긴장의 영향

제6장 생식 유전학 시장 구도

제7장 생식 유전학 시장 : 제품 유형별

제8장 생식 유전학 시장 : 용도별

제9장 생식 유전학 시장 : 시술 유형별

제10장 생식 유전학 시장 : 기술별

제11장 생식 유전학 시장 : 지역별

제12장 주요 벤더 분석 : 생식 유전학 산업

제13장 AnalystView 전방위 전망

LSH 26.10.01

Reproductive Genetics Market size was valued at US$ 8,905.1 Million in 2025, expanding at a CAGR of 20.9% from 2026 to 2033.

Reproductive genetics is a field that deals with preparing genetic tests in advance of or soon after conception in order to evaluate hereditary diseases, abnormalities of chromosome number, and genetic risks associated with embryos. It involves the use of laboratory-developed testing methods such as several tests, testing kits, reagents, consumables, and correlating molecular procedures. Within the processes of assisted reproduction, the following analytical forms of genetic testing can be mentioned: pre-implantation genetic testing for aneuploidies (PGT-A), pre-implantation genetic testing for single-gene disorders (PGT-M), and pre-implantation genetic testing for chromosomal rearrangements (PGT-SR). ACOG distinguishes these applications while emphasizing that embryo testing remains dependent on limited biopsy material and can be affected by mosaicism and false-positive or false-negative findings. The marketplace for such technologies is thus at the intersection of areas such as IVF laboratories, reproductive technologies, medical diagnostics, embryology, genetic counseling, and the regulation of genetic technology use, and the choice of products for resale is increasingly determined by the efficiency of the process.

Reproductive Genetics Market- Market Dynamics

Expansion of Genetically Informed Embryo Selection Within IVF Workflows

The driving force of demand is the growing incorporation of genetic information into the process of selecting embryos rather than the isolated growth of genetic testing. In the U.S. context, CDC statistics published in 2025 ensure national ART registration and statistics, which strengthen the data-based nature of the laboratory work of reproductive institutions. In parallel, SART recognizes that embryo banking and single-embryo transfer are crucial for modern IVF, as well as PGT, which makes it possible for embryologists to choose the embryos for transfer. All this influences the requirements for laboratories, which should be able to conduct testing based on minimal biopsy material and organize their processes of cryopreservation, sequencing, interpretation, and reporting. Therefore, suppliers are now competing more in terms of different integrations of analysis rather than the capacity of testing itself.

Reproductive Genetics Market- Segmentation Analysis:

The Global Reproductive Genetics Market is segmented on the basis of Product Type, Application, Procedure Type, Technology, and Region.

By product type, laboratory-developed tests (LDT) are pertinent when laboratories need customized assays, interpretation pathways, and workflows for diverse reproductive situations, while kits offer standard testing configurations that help ensure consistency in IVF and genetics labs. The reagents and consumables can be considered the foundational layer in the embryo biopsy process, as molecular processes rely on the ability to carry out reliable amplification, library preparation, sequencing, and maintaining a high quality of the materials. The regulatory significance of the LDT category was most evident in 2025 when it was brought to light by the fact that a federal district court declared the LDT Rule of 2024 invalid in March, and the FDA followed suit and reverted the regulation in September. Hence, regulatory positioning becomes an important factor impacting different product types.

By application, it is the specific genetic issue rather than the method of testing that distinguishes one application from another. Testing for aneuploidy is concerned with chromosome count abnormalities, while testing for single-gene disorders depends on finding known harmful genes in the family; in the case of testing for chromosomal structural abnormalities, it is about identifying translocations or inversions. A multicenter randomized study conducted in China in 2025 provides an example of the fact that PGT-A remains a subject of discussion: this study involved 450 couples suffering from severe male factor infertility and compared ICSI with and without PGT-A. This study is important as the choice of application is based not on the mere presence of laboratory equipment, but on the medical indication for intended use. This means that the market rewards those companies that can provide their platforms with multiple assay options while offering adequate interpretation and counseling.

Reproductive Genetics Market- Geographical Insights

North America's significance is primarily due to the extent and expertise of its assisted reproductive technologies system and the concentration of specialized molecular testing providers. The U.S., in its CDC surveillance, recorded 435,426 ART cycles done across 457 clinics, which highlights the magnitude of the clinical ecosystem that reproductive genetic tests enter into. Besides, it is a region with a very agile regulatory system when it comes to LDTs, since the FDA's reversal of its own 2024 regulation in 2025 has drastically changed the circumstances surrounding lab-developed reproductive tests. Thus, there is a market comprised of a high-volume chain of IVF systems and regulations that require laboratories to keep changing tests with observance of analytical validation, documentation, quality systems, and clinical expertise.

The role played by Europe in trade is highlighted by strong coordination concerning standards in reproductive medicine, clinical governance, and cross-border data infrastructure. The EuMAR program launched by ESHRE completed its first three years in 2025 and consisted of a pilot carried out in four countries: Estonia, Germany, Portugal, and Slovenia, and aimed at making it possible to monitor reproduction for every cycle. Such infrastructure is relevant in terms of reproductive genetics because standardized reproduction data allows for uniform evaluation of testing procedures and outcomes in different areas. The region has also developed recommendations on the PGT process, embryo biopsy, monogenic disorders, and chromosomal abnormalities. Thus, Europe has made its contribution to the market in terms of governance and an evidence-oriented perspective.

Reproductive Genetics Market- Competitive Landscape:

The competition is based on the capacity to connect molecular testing with the specialized work processes in IVF laboratories, as opposed to the provision of mere sequencing assays. Companies such as Natera, which specializes in reproductive genetics, sequencing platform providers, and whole-genome testing start-ups are competing to make full use of laboratory infrastructure, assays, interpretation capabilities, the speed of providing results, and clinics' access. For instance, in 2025, Luminary Life Sciences presented PGT-A Link and LinkPlus products, as well as studies related to PGT-A, monogenic infertility, and PGT-M testing. GenEmbryomics, in turn, is positioning whole-genome PGT tests focusing on the screening of over 3,200 life-threatening genetic disorders. As a result, the competition is moving from isolated tests to whole reproductive genomics processes.

Recent Developments:

In March 2025, GenEmbryomics and Progenesis signed a replacement memorandum of understanding for the year 2025 for PGT-A, PGT-M, PGT-SR, and whole-genome PGT services. Progenesis operates more than 10,000 PGT cycles that cover approximately 50,000 samples, as per company documentation filed with the SEC.

In December 2025, a multicenter randomized trial compared PGT-A with no genetic test for couples undergoing ICSI treatment for severe male infertility. The trial was conducted on 450 couples, where 225 were assigned to PGT-A and 225 were included in the control group.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL REPRODUCTIVE GENETICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Natera, Inc.
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings (LabCorp)
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • Myriad Genetics, Inc.
  • BGI Genomics
  • Eurofins Scientific SE
  • Fulgent Genetics, Inc.
  • CooperSurgical, Inc.
  • Invitae Corporation
  • Igenomix
  • Others

GLOBAL REPRODUCTIVE GENETICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Laboratory Developed Tests (LDT)
  • Kits
  • Reagents and Consumables

GLOBAL REPRODUCTIVE GENETICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Aneuploidy
  • Single Gene Disorder
  • Structural Chromosomal Abnormality
  • Others

GLOBAL REPRODUCTIVE GENETICS MARKET, BY PROCEDURE TYPE- MARKET ANALYSIS, 2020 - 2033

  • Pre-Implantation Genetic Testing
  • Carrier Screening
  • Pre-Natal Screening
  • Infertility Genetic Testing

GLOBAL REPRODUCTIVE GENETICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Next-Generation Sequencing
  • In Situ Hybridization (ISH/FISH)
  • Polymerase Chain Reaction
  • Microarray

GLOBAL REPRODUCTIVE GENETICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Reproductive Genetics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Reproductive Genetics Market Snippet by Product Type
    • 2.1.2. Reproductive Genetics Market Snippet by Application
    • 2.1.3. Reproductive Genetics Market Snippet by Procedure Type
    • 2.1.4. Reproductive Genetics Market Snippet by Technology
    • 2.1.5. Reproductive Genetics Market Snippet by Country
    • 2.1.6. Reproductive Genetics Market Snippet by Region
  • 2.2. Competitive Insights

3. Reproductive Genetics Key Market Trends

  • 3.1. Reproductive Genetics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Reproductive Genetics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Reproductive Genetics Market Opportunities
  • 3.4. Reproductive Genetics Market Future Trends

4. Reproductive Genetics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Reproductive Genetics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Reproductive Genetics Market Landscape

  • 6.1. Reproductive Genetics Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Reproductive Genetics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Laboratory Developed Tests (LDT)
    • 7.1.3. Kits
    • 7.1.4. Reagents and Consumables

8. Reproductive Genetics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Aneuploidy
    • 8.1.3. Single Gene Disorder
    • 8.1.4. Structural Chromosomal Abnormality
    • 8.1.5. Others

9. Reproductive Genetics Market - By Procedure Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2033 (%)
    • 9.1.2. Pre-Implantation Genetic Testing
    • 9.1.3. Carrier Screening
    • 9.1.4. Pre-Natal Screening
    • 9.1.5. Infertility Genetic Testing

10. Reproductive Genetics Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 10.1.2. Next-Generation Sequencing
    • 10.1.3. In Situ Hybridization (ISH/FISH)
    • 10.1.4. Polymerase Chain Reaction
    • 10.1.5. Microarray

11. Reproductive Genetics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Reproductive Genetics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Reproductive Genetics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Reproductive Genetics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Reproductive Genetics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Reproductive Genetics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Reproductive Genetics Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. F. Hoffmann-La Roche Ltd.
    • 12.2.2. Thermo Fisher Scientific Inc.
    • 12.2.3. Illumina, Inc.
    • 12.2.4. Natera, Inc.
    • 12.2.5. Quest Diagnostics Incorporated
    • 12.2.6. Laboratory Corporation of America Holdings (LabCorp)
    • 12.2.7. Agilent Technologies, Inc.
    • 12.2.8. QIAGEN N.V.
    • 12.2.9. Myriad Genetics, Inc.
    • 12.2.10. BGI Genomics
    • 12.2.11. Eurofins Scientific SE
    • 12.2.12. Fulgent Genetics, Inc.
    • 12.2.13. CooperSurgical, Inc.
    • 12.2.14. Invitae Corporation
    • 12.2.15. Igenomix
    • 12.2.16. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기